BNET Industries
Last Fiscal Year Sales:$864.9M
- Private
- UK
Dow Jones Description
Provider of Logistics & Supply Chain Management Services to Oil & Gas Exploration & Production Companies
CEO
Billy AllanNumber of Employees 1,620
Peer Companies
NAICS Code Administrative Management and General Management Consulting Services: 541611
News & Analysis
Filter by
asco plc. and immunogen inc. - All News and Analysis
ImmunoGen, Inc. Announces Presentation of Encouraging Clinical Findings with Trastuzumab-DM1 at ASCO
- 2008-06-03
WALTHAM, Mass. -- ImmunoGen, Inc. (Nasdaq: IMGN) announced today the presentation of encouraging clinical findings with trastuzumab-DM1 (T-DM1) at the 2008 American Society of Clinical Oncology ASCO Annual Meeting taking place in Chicago, IL. T-DM1 comprises ImmunoGen's DM1 cell-killing agent linked to Genentech's HER2-targeting antibody, trastuzumab. Genentech is developing T-DM1...
ImmunoGen, Inc. Announces Clinical Findings Reported at ASCO with Targeted Anticancer Compounds IMGN242 and AVE1642
- 2008-06-01
WALTHAM, Mass. -- ImmunoGen, Inc. (Nasdaq: IMGN) today announced that encouraging clinical findings with the targeted anticancer compounds IMGN242 and AVE1642 were reported at the 2008 American Society of Clinical Oncology ASCO Annual Meeting taking place in Chicago, IL.
ImmunoGen, Inc. Announces Presentations at Upcoming 2008 American Society of Clinical Oncology Annual Meeting
- 2008-05-23
WALTHAM, Mass. -- ImmunoGen, Inc. (Nasdaq: IMGN) today announced that new clinical data will be reported at the 2008 American Society of Clinical Oncology ASCO Annual Meeting with three targeted anticancer compounds in development by the Company and its collaborators. The ASCO annual meeting will be held May 30 to...
ImmunoGen, Inc. Announces Clinical Data Reported at ASCO
- 2007-06-03
- Genentech Also Announces Decision to Advance Trastuzumab-DM1 to Phase II Testing -
- 1
Decision Makers
| Name (plus bio) | Position |
|---|---|
| Billy Allan | CEO |
| Bill Loch | Director, Strategic Dev |
| Derek Smith | Director, Operations |
| Ian Ross | Director, Finance |
Board of Directors
| Name (plus bio) | Position |
|---|---|
| Mike Salter | Chairman |
| Hugh Lenon | Board of Directors |
| Jim Cooper | Board of Directors |
| Richard Daw | Board of Directors |
| Rodney Lenthall | Board of Directors |
| Organization | Position | Status |
|---|---|---|
| Asco plc | Director, Strategic Dev | Current |
| Asco plc | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Asco plc | Director, Operations | Current |
| Asco plc | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Asco plc | Chairman | Current |
| Organization | Position | Status |
|---|---|---|
| Asco plc | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Asco plc | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Asco plc | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Asco plc | Board of Directors | Current |
Industry Transcripts by Seeking Alpha
-
51jobs Q3 2009 Earnings Call Transcript
on Nov 23, 2009about JOBS
-
NetEase Q3 2009 Earnings Call Transcript
on Nov 18, 2009about NTES
-
Franklin Covey Co. F4Q09 (Qtr End 08/31/09) Earnings Call Transcript
on Nov 16, 2009about FC
-
Cellcom Israel Ltd. Q3 2009 Earnings Call Transcript
on Nov 16, 2009about CEL
-
URS Corporation Q3 2009 Earnings Call Transcript
on Nov 13, 2009about URS
Glass Door
ASCO (United Kingdom)
IndustryTop Rated
